Christos Emmanouilides1, Stavros Tryfon2, Sofia Baka3, Hercules Titopoulos4, Albert Dager5, Dimitrios Filippou5. 1. Department of Oncology, Thessaloniki, Greece cemmanou@yahoo.gr. 2. Pulmonary Clinic, General Hospital "G. Papanikolaou", Thessaloniki, Greece. 3. Department of Oncology, Thessaloniki, Greece. 4. Department of Pulmonary Medicine, Thessaloniki, Greece. 5. Cardiothoracic Surgery at Interbalkan European Medical Center, Thessaloniki, Greece.
Abstract
BACKGROUND/AIM: Lobar reimplantation techniques enable the safe resection of lung cancer when pneumonectomy is not desirable or not feasible. We report our experience with this procedure. PATIENTS AND METHODS: Patients with difficult to resect upper/middle lobe non-small cell lung cancer were included. In situ reimplantation technique requires the reanastomosis of the pulmonary vein of the healthy lower lobe to the upper lobe stump; bench surgery reimplantation involves the ex vivo surgical treatment of the whole excised lung and subsequent reimplantation of the healthy remnant. RESULTS: Nine patients with upper-middle lobe lung cancer underwent in situ reimplantation, mean age=70.7±4.2 years; 6 patients underwent ex situ resection, mean age=64.3±18.4 years. One obese patient succumbed due to thrombosis of the anastomosed pulmonary vein. One patient developed a stroke. CONCLUSION: The procedure was in general well-tolerated and enables for curative resection of otherwise unresectable lung cancer. Copyright
BACKGROUND/AIM: Lobar reimplantation techniques enable the safe resection of lung cancer when pneumonectomy is not desirable or not feasible. We report our experience with this procedure. PATIENTS AND METHODS: Patients with difficult to resect upper/middle lobe non-small cell lung cancer were included. In situ reimplantation technique requires the reanastomosis of the pulmonary vein of the healthy lower lobe to the upper lobe stump; bench surgery reimplantation involves the ex vivo surgical treatment of the whole excised lung and subsequent reimplantation of the healthy remnant. RESULTS: Nine patients with upper-middle lobe lung cancer underwent in situ reimplantation, mean age=70.7±4.2 years; 6 patients underwent ex situ resection, mean age=64.3±18.4 years. One obesepatient succumbed due to thrombosis of the anastomosed pulmonary vein. One patient developed a stroke. CONCLUSION: The procedure was in general well-tolerated and enables for curative resection of otherwise unresectable lung cancer. Copyright